Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dTpa Vaccine Booster in Healthy Japanese Adolescents
NCT07596173Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2026
- Primary completion
- Sep 2026
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed in diphtheria, Tetanus, pertussis, sponsored by GSK. Started Jun 2026; status: completed.
02
Drugs
diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT07596173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07596173.